Gut microbe metabolite found to modulate heart disease risk through β2-adrenergic receptors Study identifies phenylacetylglutamine (PAGln), a gut microbiome metabolite, as a novel allosteric modulator of β2-adrenergic receptors, offering insights into its role in cardiovascular disease (CVD)...

Gut microbe metabolite found to modulate heart disease risk through β2-adrenergic receptors 💊🧬❤️ www.news-medical.net/news/2024082... #Cardiovascular #GutMicrobiome #HeartDisease #Bioprospecting #DrugDiscovery #β2Receptors #Phenylacetylglutamine #Metabolic